Latest / The Commercial Awareness Compass by AllAboutLaw
Patent pending: how Trump’s pharma tariff shakes global medicine | Commercial Awareness Compass #54
President Trump has proposed a one hundred per cent tariff on branded and patented pharmaceutical imports, due to take effect unless manufacturers shift production to the United States by October 2025. The measure is part of a wider plan to rebuild domestic manufacturing and reduce the US trade deficit. Officials say it will strengthen national security, but the pharmaceutical industry has warned of major disruption to global supply chains and rising drug prices across Europe and beyond.
The proposal raises difficult questions for both governments and lawyers. How would a policy like this…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.